Drugs Pharmaceuticals Small Molecule Synthetic Chemistry 
Drug Discovery World
MARCH 12, 2024
RA: Biomia is developing drug candidates for pain, addiction and mental health conditions. What are some of the historical challenges with these drugs? RA: What advantages does a plant-based approach bring to drug development? Also, most second- generation antipsychotics have delayed onset, which may influence patient adherence.
DrugBaron
FEBRUARY 7, 2022
Finding small molecule drugs is much harder than finding a needle in a haystack – discovering the right arrangement of atoms to bind precisely to a protein target to elicit a particular response is a problem of vast dimensionality. Yet the situation with small molecules is even worse.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Discovery World
NOVEMBER 17, 2022
Lu Rahman selects some recent synthetic biology innovations and the potential they hold to benefit drug discovery. . The rapidly growing area of synthetic biology – including molecular biology, biotechnology, biophysics, and genetic engineering – is having a marked impact on the drug discovery landscape.
The Pharma Data
DECEMBER 4, 2021
As a result, Pfizer can maximize uptime for equipment such as centrifuges, agitators, pulverizers, coaters, and air handlers used in clinical drug manufacturing. The overall focus of this collaboration is to support Pfizer in more rapidly and reliably producing new drugs and evaluating their potential health benefit for patients.
The Strateos Blog: Drug Discovery
AUGUST 16, 2021
On July 20th, Strateos hosted a webinar entitled Drug Discovery and Medicinal Chemistry in the Era of Automation. To advance a lead candidate through to clinical trials in traditional small molecule pipelines, it can take on average 6+ years. Daniel Rines, Ph.D., Director of R&D Strategy and Vince Yeh, Ph.D.,
Expert insights. Personalized for you.
147 
Let's personalize your content